Dr. Kyle Holen is an oncologist practicing in Madison, WI. Dr. Holen specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Holen manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Columbia Univ Coll of Physicians And Surgeons, New York Ny 1996
Internal MedicineAmerican Board of Internal MedicineABIM
- New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
- Target practice: figuring out which, when, and why to use systemic therapies for metastatic colon cancer.
- A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas.
- Guillain-Barré syndrome after treatment with sunitinib malate?
- A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.
- Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma.
- A phase I study of an oral simulated FOLFOX with high dose capecitabine.
- Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.
- Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.
- More on reports of esophageal cancer with oral bisphosphonate use.
- Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.
- The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.
- A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.
- Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
- Ny And Presby Hosp, Internal Medicine
- Ny and Presby Hospital
Dr. Kyle D Holen MD's Practice location
Dr. Kyle D Holen MD's reviewsWrite Review
- Sandra Lee, Breast Cancer Survivor, Wants You to be Neurotic About Your Health
October is referred to in the United States as National Breast Cancer Awareness Month. In honor of the annual campaign dedicated to raising awareness of the disease, Sandra Lee’s documentary short - “RX Early Detection: A Cancer Journey with Sandra Lee” - is filled with wry humor, tears, and...
- Possibly All Ovarian Cancer Starts in Fallopian Tubes, Research Suggests
There are many different types of ovarian cancers and recent research is suggesting that most, if not all start in the fallopian tubes. This is an important breakthrough. By understanding more about how and where ovarian cancers start, clinicians and researchers can work on new prevention and...
- What Procedures are Used to Treat Ovarian Cancer?
Ovarian cancer is an unpleasant and dangerous disease that can affect every woman in the world. There are many risk factors that can cause this condition, and the disease can easily affect other organs near the ovaries, including the womb, the bladder, and the colon. Fortunately, there are many...
- Chemotherapy for Cervical Cancer
What is chemotherapy?Chemotherapy is a form of cancer treatment that uses medicine to kill the cancer cells. The cancer cells are being damaged and killed so that they will not be able to reproduce and spread. It is usually used if there is a risk that cancer will spread or when it has already...
- What Medical Conditions Are Associated with Blood in Urine?
Introduction:Blood in urine is more often than not a sign that there is something amiss in the body. It may signal a minor infection that need not worry you, but it could also be pointing to something more serious that is still undetected. Even if you appear to be in reasonably good health, it is...
- Fetal Exposure to Chemotherapy May Not Affect the Development of the Child
A new study has given reassuring results for mothers who are under chemotherapy treatment for cancer. The study results show that fetal exposure to chemotherapy after the first trimester may not cause health problems or developmental delays in the child. In this study published in the journal...
- Dr. Ruth M O'regan MD600 HIGHLAND AVE MADISON WI 53792
- Dr. Glenn Liu MD600 Highland Ave Madison WI 53792
- Dr. Daniel L Mulkerin MD600 Highland Ave Madison WI 53792
- Dr. Mark Edward Burkard M.D.600 Highland Ave Madison WI 53792
- Dr. Noelle K Loconte MD600 Highland Ave Madison WI 53792
- Dr. Paul R Kaesberg MD600 Highland Ave Madison WI 53792